Albemarle financials
$107.62+0.21%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.14B | $5.38B | $9.62B | $7.32B | $3.33B | $3.13B | $3.59B | $3.37B | $3.07B | $2.68B |
| Gross profit | $668.7M | $62.5M | $1.19B | $3.07B | $998.0M | $994.9M | $1.26B | $1.22B | $1.11B | $970.3M |
| Gross margin | 13.0% | 1.2% | 12.3% | 42.0% | 30.0% | 31.8% | 35.0% | 36.1% | 36.0% | 36.2% |
| Operating income | -$367.1M | -$1.78B | $180.7M | $2.48B | $502.5M | $505.8M | $666.1M | $701.1M | $571.7M | $478.7M |
| Net income | -$677.4M | -$1.32B | $1.57B | $2.69B | $123.7M | $375.8M | $533.2M | $693.6M | $54.9M | $643.7M |
| Net margin | −13.2% | −24.5% | 16.4% | 36.7% | 3.7% | 12.0% | 14.9% | 20.6% | 1.8% | 24.0% |
| Diluted EPS | $-5.76 | $-11.20 | $13.36 | $22.84 | $1.06 | $3.52 | $5.02 | $6.34 | $0.49 | $5.68 |
| EBITDA | $726.0M | -$53.6M | $620.1M | $2.78B | $756.5M | $737.8M | $879.6M | $901.8M | $768.6M | $762.2M |
| Operating cash flow | $1.28B | $687.9M | $1.33B | $1.91B | $344.3M | $798.9M | $719.4M | $546.2M | $304.0M | $735.5M |
| Free cash flow | $692.5M | -$992.7M | -$828.0M | $646.2M | -$609.4M | -$51.6M | -$132.4M | -$153.8M | -$13.7M | $538.9M |
| Diluted shares | 117.7M | 117.5M | 117.8M | 117.8M | 116.5M | 106.8M | 106.3M | 109.5M | 112.4M | 113.2M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.62B | $1.19B | $889.9M | $1.50B | $439.3M | $746.7M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $3.19B | $3.52B | $4.17B | $3.22B | $2.39B | $3.57B |
| Total assets | $16.37B | $16.61B | $18.27B | $15.46B | $10.97B | $10.45B |
| Total liabilities | $6.59B | $6.41B | $8.61B | $7.27B | $5.17B | $5.98B |
| Shareholders' equity | $9.78B | $10.20B | $9.67B | $8.19B | $5.81B | $4.47B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology